FDA Compliance 2012 - CFR 21 Part 11 and Annex 11: How to Avoid the Audit Traps
Date2012-04-04
Deadline2012-04-04
VenuePalo Alto, USA - United States
KeywordsFDA Audit; CFR 21 Part 11; Annex 11 Audit; ERES, Part 11 Enforcement; Annex 11; Predicate rules; systems audit; 483s; warning letters
Topics/Call fo Papers
This 90-minute webinar on Part 11/Annex 11 audit and enforcement will tell you what the auditors are trained to look for during a Part 11/Annex 11 “tag along” audit.
Regulatory compliance requirements for CFR 21 Part 11/Annex 11 (also known as ERES) have undergone several revisions since its inception during the late 1990s. While the agencies have endeared themselves to the industry by adopting a flexible audit approach for ERES, they are increasingly requiring companies to comply with the regulations.
Areas Covered:
- Predicate rules and Part 11/Annex 11 requirements overview
- Dependencies between Predicate rules and Part 11/Annex 11
- Similarities and differences between Part 11 and Annex 11
- Part 11/Annex 11 related SOPs
- What are auditors trained to look for during a Part 11/Annex 11 "tag along" audit
- Inspection trends with examples of some recent 483s and WL
Other CFPs
- Special Session for Intelligent Decision Support for Highly Ill-Structured Decision Problems (SS-IDS 2012)
- 2012 Workshop of Information Security
- Raw Materials Risk Management in GMP Facilities: Avoiding GMP non-Compliance Due to Raw Material Issues
- Making All Data Count: FDA Acceptance of non-US Clinical Trials
- Software validation and 21 CFR Part 11 remediation planning: FDA inspection strategies
Last modified: 2012-03-19 14:46:01